GMT GenomicsS.A.Active
Research and experimental development in natural sciences and engineering
Overview
Gmt Genomics is the creator of Genomtec ID, a mobile platform for genetic diagnostics at the point of patient care. They have developed the GenomtecID Respiratory Panel 5-Plex (RP5-PLEX), which is designed to detect viruses and bacteria responsible for respiratory tract infections and is the only solution of its kind in Europe. The company is also involved in technology trials and M&A efforts in Asia related to their diagnostic devices.
News
Another patent granted. Another step in building global protection of Genomtec molecular diagnostics technology
Genomtec secured 11 million PLN from share issue for finalizing global M&A strategy and commercialization of breakthrough Genomtec ID and OncoSNAAT® technologies
Start of Genomtec public share offering to raise funds for finalizing M&A process and commercialization of Genomtec ID and OncoSNAAT® technologies
Genomtec plans share issue. Funds will support M&A process and project commercialization. Company signed investment agreement with key shareholder.
Genomtec prepares to test its technology with potential partners in Asia as part of M&A process
Genomtec Supervisory Board appointed Leroy Huntley to the Management Board
Accounts
- 26 1090 2398 0000 0001 6486 6619
- 44 1090 2398 0000 0001 6486 6586
- 65 1090 2398 0000 0001 6186 7744
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| REAL ResearchS.A. | $565,296.66 | real-research.com/ | |
| BioceltixS.A. | $492,206.18 | bioceltix.com/ | |
| PolbionicaS.A. | $225,022.81 | polbionica.com/ | |
| NanosanguisS.A. | $133,800.85 | nanosanguis.com | |
| SatroecgS.A. | $117,301.57 | satroecg.pl | |
| Smart FluidS.A. | $100,333.00 | smartfluid.pl | |
| IncellvuS.A. | $82,908.93 | incellvu.pl | |
| NanovelosS.A. | $22,690.62 | nanovelos.com | |
| ARES Shield AiS.A. | $21,335.85 | aresshield.ai | |
| NanotheaS.A. | $12,468.28 | nanothea.com |
FAQ
Last updated: 2026-05-11